To top

Areas of Expertise

Dr McDonald performs a range of treatments including:

Some of the conditions he commonly treats are:

  • Acne
  • Eczema
  • Psoriasis
  • Hidradenitis suppurativa
  • Skin cancer

Career highlights

Dr Bryan McDonald has received the following qualifications

  • 2000 Medical Degree (MB, BCh, BAO)
  • 2002 Diploma Geriatric Medicine
  • 2003 Diploma Royal College Obstetricians and Gynaecologists
  • 2004 Membership of Royal College of GP
  • 2005 Membership of Royal College Physicians
  • 2006 Diploma in Practical Dermatology
  • 2007 Diploma of the Faculty of Family Planning
  • 2007 Diploma in Primary Care Diabetes Management
  • 2009 Diploma in Occupational Medicine
  • 2014 Specialist Certificate Examination in Dermatology


Dr Bryan McDonald has achieved multiple publications in peer-reviewed journals.

Key Publications

  • Muralidharan V, Pathmarajah P, Peterknecht E, Qazi E, Barlow R, Vivek M, Abdullah A, McDonald B and Bewley A. Real life data on the biopsychosocial effects of Adalimumab in the management of hidradenitis suppurativa: A multicenter cross sectional analysis and consideration of a multi system monitoring approach to follow up. Dermatologic Therapy. 2020 Dec 9;e14643. doi: 10.1111/dth.14643. Online ahead of print.
  • McDonald B. Utility of faecal calprotectin testing in dermatology. Clinical and Experimental Dermatology, 2020 Oct; doi:10.1111/ced.14484
  • McDonald BS, Pigors M, Kelsell DP, O’Toole EA, Burkitt-Wright E, Kerr B and Batta K. Noonan syndrome with multiple lentigines and associated craniosynostosis. Clinical and Experimental Dermatology. 2018; 43(3): 357-9
  • McDonald BS, Narayanan S, Elawad M, Kiparissi F, Cullup T and Batta K. Interleukin-10 receptor mutation presenting with severe nappy ulceration and infantile inflammatory bowel disease. Clinical and Experimental Dermatology. 2017; 42(7): 771-773
  • McDonald B and White J. Review of 35 years of paediatric patch testing in a tertiary-care centre. Contact Dermatitis. 2016;75(s1):58
  • McDonald BS, Jones J and Rustin M. Rituximab as a treatment for severe atopic eczema: failure to improve in three consecutive patients. Clinical and Experimental Dermatology. 2016;41(1):45-47